AUROPHARMA Intraday Analysis...

AUROPHARMA Share Price

Open 682.40 Change Price %
High 683.50 1 Day -8.75 -1.29
Low 669.35 1 Week -10.30 -1.51
Close 670.25 1 Month -6.95 -1.03
Volume 1460926 1 Year -66.25 -9.00
52 Week High 895.00
52 Week Low 621.90
AUROPHARMA Important Levels
Resistance 2 683.37
Resistance 1 677.96
Pivot 674.37
Support 1 662.54
Support 2 657.13
NSE INDIA Most Active Stocks
JPASSOCIAT 13.80 1.85%
SUZLON 18.25 -1.08%
UVSL 0.70 -6.67%
SBIN 288.45 2.25%
ASHOKLEY 84.00 -2.83%
IDEA 88.90 0.45%
BANKBARODA 173.50 -0.23%
UNITECH 5.45 -2.68%
ICICIBANK 282.20 1.88%
RCOM 38.15 -0.65%
More..
NSE INDIA Top Gainers Stocks
VKSPL 0.10 100.00%
AUSTRAL 0.30 20.00%
FCSSOFT 0.30 20.00%
UCALFUEL 218.70 20.00%
KOLTEPATIL 185.20 14.18%
DQE 21.60 12.79%
VSSL 134.20 12.44%
KANANIIND 17.05 11.44%
TRITURBINE 142.20 11.40%
SHALPAINTS 166.40 11.01%
More..
NSE INDIA Top Losers Stocks
HINDZINC 290.05 -11.03%
LAKSHMIEFL 60.30 -10.33%
NICCO 0.45 -10.00%
RESPONIND 86.75 -9.35%
FILATEX 114.25 -9.18%
KKCL 1643.00 -8.84%
GRAVITA 57.55 -8.43%
SKIL 20.25 -8.37%
GTNTEX 17.90 -8.21%
NTL 4.50 -8.16%
More..

Aurobindo Pharma Limited (NSE: AUROPHARMA)

AUROPHARMA Technical Analysis 4
As on 29th Mar 2017 AUROPHARMA Share Price closed @ 670.25 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 745.48 & Sell for SHORT-TERM with Stoploss of 684.22 we also expect STOCK to react on Following IMPORTANT LEVELS.
AUROPHARMA Target for March
1st Target up-side 724.29
2nd Target up-side 757.29
3rd Target up-side 790.3
1st Target down-side 630.11
2nd Target down-side 597.11
3rd Target down-side 564.1
AUROPHARMA Synopsis Technicals View
50 Day EMA Close is Below EMA 50 (Short Term)
Bearish
100 Day EMA Close is Below EMA 100 (Mid Term) Bearish
200 Day EMA Close is Below EMA 200 (Long Term) Bearish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is 46.68 Sideways
MFI (14) MFI is 57.36 Sideways
CCI (20) CCI is -16.91 Sideways
WILLIAM %R (14) William %R is -66.34 Sideways
ADX (14) ADX is 12.80 Range Bound
PSAR Stoploss For Long Buy 665.25
10 Day Avg Volume Traded -21.66 % Less then 10 Day Average Volume
AUROPHARMA Other Details
Segment EQ
Market Capital 25150871552.00
Sector Pharmaceuticals
Industry
Offical website
AUROPHARMA Address
AUROPHARMA
N/A
AUROPHARMA Latest News
Interactive Technical Analysis Chart Aurobindo Pharma Limited ( AUROPHARMA NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Aurobindo Pharma Limited
AUROPHARMA Business Profile
Aurobindo Pharm is in the Pharmaceuticals sector. Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly committed professionals, Aurobindo Pharma was born off a vision. The company commenced operations in 1988-89 with a single unit manufacturing Semi-Synthetic Penicillin (SSP) at Pondicherry. Aurobindo Pharma became a public company in 1992 and listed its shares in the Indian stock exchanges in 1995. In addition to being the market leader in Semi-Synthetic Penicillins, it has a presence in key therapeutic segments such as neurosciences, cardiovascular, anti-retrovirals, anti-diabetics, gastroenterology and cephalosporins, among others. Aurobindo makes use of in-house R&D for rapid filing of patents, Drug Master Files (DMFs), Abbreviated New Drug Applications (ANDAs) and formulation dossiers across the world. Aurobindo Pharma is among the largest filers of DMFs and ANDAs from India. The current market capitalisation stands at Rs 8,284.96 crore.The company has reported a consolidated sales of Rs 1913.86 crore and a Net Profit of Rs 233.86 crore for the quarter ended Sep 2013. The company management includes K Ragunathan - Non Executive Chairman, K Nithyananda Reddy - Vice Chairman & Whole Time Dir, N Govindarajan - Managing Director, M Sivakumaran - Whole Time Director, M Madan Mohan Reddy - Whole Time Director, P V Ramprasad Reddy - Non Executive Director, P Sarath Chandra Reddy - Non Executive Director, M Sitarama Murthy - Non Executive Director, D Rajagopala Reddy - Non Executive Director, C Channa Reddy - Non Executive Director. It is listed on the BSE with a BSE Code of 524804 and the NSE with an NSE Code of AUROPHARMA. Its Registered office is at Plot No. 2, Maitrivihar,,Ameerpet Hyderabad,Andhra Pradesh - 500038.